Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329Pharmaceuticals
CN¥39.98−1.26%As of Oct 29vs prior close
- Market cap
- $3.4B
- P/E (TTM)
- 36.3×
- P/E (FY1)
- 29.8×
- From 52W high
- −20.12%
- EPS (LTM)
- CN¥1.11
- Revenue (LTM)
- CN¥4.7B
- Net margin
- 17.96%
Nomior Score
29
Steady ProfileBottom 14% of the scored universe
Growth47
Quality59
Value27
Momentum5
Resilience55
Growth
−15.84%revenue a year over 3 fiscal years
YE22 CN¥8.2BLTM CN¥4.7B
Connections
Revenue to profitYE25
43% of revenue became net profit, up 13 pts on a year.